1. Home
  2. RHP vs ICUCW Comparison

RHP vs ICUCW Comparison

Compare RHP & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RHP
  • ICUCW
  • Stock Information
  • Founded
  • RHP 1991
  • ICUCW N/A
  • Country
  • RHP United States
  • ICUCW United States
  • Employees
  • RHP N/A
  • ICUCW 12
  • Industry
  • RHP Real Estate Investment Trusts
  • ICUCW Biotechnology: Pharmaceutical Preparations
  • Sector
  • RHP Real Estate
  • ICUCW Health Care
  • Exchange
  • RHP Nasdaq
  • ICUCW Nasdaq
  • Market Cap
  • RHP N/A
  • ICUCW N/A
  • IPO Year
  • RHP 1991
  • ICUCW 2021
  • Fundamental
  • Price
  • RHP $115.65
  • ICUCW $0.03
  • Analyst Decision
  • RHP Strong Buy
  • ICUCW
  • Analyst Count
  • RHP 6
  • ICUCW 0
  • Target Price
  • RHP $126.17
  • ICUCW N/A
  • AVG Volume (30 Days)
  • RHP 491.2K
  • ICUCW N/A
  • Earning Date
  • RHP 11-04-2024
  • ICUCW N/A
  • Dividend Yield
  • RHP 3.80%
  • ICUCW N/A
  • EPS Growth
  • RHP 50.95
  • ICUCW N/A
  • EPS
  • RHP 5.77
  • ICUCW N/A
  • Revenue
  • RHP $2,335,597,000.00
  • ICUCW N/A
  • Revenue This Year
  • RHP N/A
  • ICUCW N/A
  • Revenue Next Year
  • RHP $3.49
  • ICUCW N/A
  • P/E Ratio
  • RHP $20.06
  • ICUCW N/A
  • Revenue Growth
  • RHP 12.62
  • ICUCW N/A
  • 52 Week Low
  • RHP $93.76
  • ICUCW N/A
  • 52 Week High
  • RHP $122.91
  • ICUCW N/A
  • Technical
  • Relative Strength Index (RSI)
  • RHP 64.91
  • ICUCW N/A
  • Support Level
  • RHP $109.58
  • ICUCW N/A
  • Resistance Level
  • RHP $115.49
  • ICUCW N/A
  • Average True Range (ATR)
  • RHP 3.14
  • ICUCW 0.00
  • MACD
  • RHP 0.21
  • ICUCW 0.00
  • Stochastic Oscillator
  • RHP 82.22
  • ICUCW 0.00

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.

Share on Social Networks: